Researcher biography

I completed my doctoral degree as part of the International PhD Program at Institute Pasteur (Paris, France) in 2012. During my PhD, I established myself as a key researcher in the field of NK cell response to systemic inflammatory response syndrome and sepsis in animal models and intensive care unit (ICU) patients. In 2013, I joined the Immunology in Cancer and Infection Laboratory at QIMR Berghofer, and in 2016 I joined the Immunotherapy Laboratory at the Walter and Elisa Hall Institute to extend my knowledge in the areas of cancer immunoediting and immunotherapy under Prof. Nick Huntington mentorship. I started my track record of independence by attracting peer reviewed funding: a NHMRC ECF Peter Doherty Fellowship, a NHMRC New Investigator Project Grant, a National Breast Cancer Foundation Fellowship, three Cure Cancer Australia PdCCRS Project Grants, and a Weekend to End Women's Cancer Grant as sole chief investigator. From my postdoctoral training, I have an extensive track record of publications in top tier journals including Blood, Cell Death Dis, JEM, PNAS, Nat Comms and Nat Immunol (total 59 papers since 2009 including: 20 as first author, 7 invited reviews in 5 of which as corresponding author, 4 as corresponding author in research reports). My work in the identification of new regulator of optimal in vivo NK cell function has earned me peer recognition as an emerging leader in the field. My current projects as a research group leader at the University of Queensland Diamantina Institute in Brisbane, aim to identify and translate the role of NK cells and innate immunity in the development of metastatic cancer or persistent bacterial infections.